Abstract:Purpose: To develop a technique with clinical 3.0-T magnetic resonance (MR) imaging to delineate local contrast agent distribution in coronary artery walls for potential molecular MR imaging-guided local gene or drug therapy of atherosclerotic coronary artery disease.Materials and methods: This animal protocol was approved by the institutional animal care and use committee and was in compliance with the Guide for the Care and Use of Laboratory Animals. For in vitro confirmation, human arterial smooth muscle cells (SMCs) were used to determine capability of SMCs in uptake of motexafin gadolinium (MGd) and its optimal dose. For ex vivo evaluation, a 2-mL mixture of MGd and trypan blue was locally infused into coronary artery walls of six cadaveric pig hearts with MR monitoring and an MR imaging guidewire, surface coils, or both. For in vivo validation, the balloon catheter was placed into coronary arteries of seven living pigs, and the MGd and trypan blue mixture was infused into arterial walls with MR guidance. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of coronary artery walls were recorded by using different coils between pre-and postcontrast infusion, with subsequent histologic confirmation. Paired Student t tests were used to compare average SNRs and CNRs of arterial walls before and after contrast agent infusion with different coils.Results: SMCs could take up MGd with the optimal concentration at 150 mu mol/L. Average SNR with the MR imaging guidewire and surface coil combination was significantly higher than that with the MR imaging guidewire only or with surface coils only (P < .05), and average SNR and CNR of postinfusion MR imaging was significantly higher than that of preinfusion MR imaging (P < .05). Histologic analysis was used to confirm successful intracoronary infiltration of MGd and trypan blue within coronary artery walls.Conclusion: MR imaging can be used to delineate locally infused contrast agent distribution in coronary artery walls. This establishes groundwork for development of molecular MR imaging-guided intracoronary therapy. (C) RSNA, 2013

MR Targeted Imaging for the Expression of Tenascin-C in Myocardial Infarction in Vivo.

MR Targeted Imaging for the Expression of Tenascin-C in Cervical Cancer.

In vivo MRI detection of atherosclerosis in ApoE-deficient mice by using tenascin-C-targeted USPIO.

[MR Imaging of Injected Magnetically Labeled Stem Cells in Myocardial Infarction: Experiment with Pigs].

Myocardial Infarction Quantification with Late Gadolinium-Enhanced Magnetic Resonance Imaging in Rats Using a 7-T Scanner.

3.0-T Mr Imaging of Intracoronary Local Delivery of Motexafin Gadolinium into Coronary Artery Walls

In Vivo Magnetic Resonance Imaging of Injected Endothelial Progenitor Cells after Myocardial Infarction in Rats

Identification and Differentiation of Magnetically Labeled Mesenchymal Stem Cells in Vivo in Swines with Myocardial Infarction.

Application of MRI for Assessment of Myocardial Viability in a Pig Model

Assessment of Cell Infiltration in Myocardial Infarction: a Dose-Dependent Study Using Micrometer-Sized Iron Oxide Particles.

MRI in myocardial infarction:experimental trial and preliminary clinical report

In Vivo Cardiac Magnetic Resonance Imaging of Superparamagnetic Iron Oxides-Labeled Mesenchymal Stem Cells in Swines

Quantitative assessment of salvaged myocardial zone and intramyocardial hemorrhage using non-contrast faster T2 mapping in a rat model by 7T MRI.

Molecular Imaging to Monitor Repair of Myocardial Infarction Using Genetically Engineered Bone Marrow-Derived Mesenchymal Stem Cells.

Delayed magnetic resonance imaging for survived myocardium in pigs with myocardial infarction

Novel PET/CT tracers for targeted imaging of membrane receptors to evaluate cardiomyocyte apoptosis and tissue repair process in a rat model of myocardial infarction

Targeted detection of inflammatory 'imprint' in ischemic myocardium by ultrasound microbubbles with sialyl lewisX

In vivo MRI of embryonic stem cells in a mouse model of myocardial infarction.

MRI with Necrosis-Avid Contrast Agent for the Assessment of Myocardial Viability in a Swine Model

3D T1-weighted Self-Gated Cardiac MRI for Assessing Myocardial Infarction in Mouse Models

Histological Validation of Cardiovascular Magnetic Resonance T1 Mapping for Assessing the Evolution of Myocardial Injury in Myocardial Infarction: an Experimental Study